Yahoo
NasdaqCM - BOATS Real Time Price USD

Vistagen Therapeutics, Inc. (VTGN)

0.1638 -0.0014 (-0.85%)
At close: November 6 at 4:00:00 PM EST
0.1687 +0.0049 (+2.99%)
Overnight: 10:46:18 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
2,501
1,269
486
1,064
-227
Operating Expense
72,171
73,395
56,459
34,085
59,041
Operating Income
-69,670
-72,126
-55,973
-33,021
-59,268
Net Non Operating Interest Income Expense
2,049
2,441
4,557
3,351
26
Other Income Expense
8
7
5
312
--
Pretax Income
-67,613
-69,678
-51,411
-29,358
-59,242
Tax Provision
7
7
7
4
6
Net Income Common Stockholders
-67,620
-69,685
-51,418
-29,362
-59,248
Diluted NI Available to Com Stockholders
-67,620
-69,685
-51,418
-29,362
-59,248
Basic EPS
-1.66
-1.83
-1.67
-1.52
-8.51
Diluted EPS
-1.66
-1.83
-1.67
-1.52
-8.51
Basic Average Shares
40,836.3030
38,073.9260
30,877.0290
19,354.5000
6,959.4440
Diluted Average Shares
40,836.3030
38,073.9260
30,877.0290
19,354.5000
6,959.4440
Total Operating Income as Reported
-69,670
-72,126
-55,973
-33,021
-59,268
Rent Expense Supplemental
--
--
--
--
419
Total Expenses
72,171
73,395
56,459
34,085
59,041
Net Income from Continuing & Discontinued Operation
-67,620
-69,685
-51,418
-29,362
-59,248
Normalized Income
-67,620
-69,685
-51,418
-29,362
-59,248
Interest Income
2,049
2,441
4,557
3,351
49
Interest Expense
--
--
--
--
23
Net Interest Income
2,049
2,441
4,557
3,351
26
EBIT
-69,670
-72,126
-55,973
-33,021
-59,268
EBITDA
-68,909
-71,393
-55,338
-32,453
-58,736
Reconciled Depreciation
761
733
635
568
532
Net Income from Continuing Operation Net Minority Interest
-67,620
-69,685
-51,418
-29,362
-59,248
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-68,909
-71,393
-55,338
-32,453
-58,736
Tax Rate for Calcs
0.0004
0.0004
0.0003
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2023 - 6/21/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: